Despite overall low pediatric head injury mortality, disparities exist between races

Richard A Falcone1, Colin Martin, Rebeccah L Brown

  • 1Division of Pediatric and Thoracic Surgery, Department of Surgery, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229-3039, USA. richard.falcone@cchmc.org

Insights

This study found that while overall outcomes for pediatric head injuries are good, African American children face higher mortality rates compared to white children. Further investigation into these racial disparities in head injury care is crucial.

Area of Science:

  • Pediatric Traumatology
  • Public Health
  • Health Equity

Background:

  • Evaluating outcomes in pediatric head injury care is essential for quality improvement.
  • Assessing outcomes across diverse patient groups is critical for identifying disparities.

Purpose of the Study:

  • To compare overall and race-specific mortality rates in children with head injuries.
  • To investigate potential racial disparities in head injury outcomes using local and national data.

Main Methods:

  • Data were extracted from the National Trauma Data Bank and a local trauma registry.
  • Unadjusted and adjusted analyses, including logistic regression, were performed to assess mortality.
  • Stratified analysis was used to examine race-specific outcomes.

Main Results:

  • A total of 16,474 children with head injuries were analyzed (13,363 national, 3111 local).
  • Local mortality rates (3.2%) were lower than national rates (6.8%).
  • African American children experienced significantly higher mortality (5.3%) than white children (2.2%) in local data, with race identified as an independent predictor (OR 3.1).

Conclusions:

  • Despite favorable overall outcomes, significant racial disparities in mortality exist for pediatric head injuries.
  • African American children face a higher risk of mortality following head injury.
  • These findings underscore the necessity of subgroup analysis to uncover and address health inequities.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: